Parkman Healthcare Partners LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Parkman Healthcare Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $1.48 Million - $1.95 Million	-25,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $725,250 - $1.86 Million	25,000 New	25,000 $1.83 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $550,200 - $1.15 Million	-20,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$40.86 - $57.65 $817,200 - $1.15 Million	20,000 New	20,000 $1.09 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.